$867 Million is the total value of BROADWOOD CAPITAL INC's 7 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STAA | STAAR SURGICAL CO | $381,265,000 | +36.4% | 10,840,630 | 0.0% | 43.96% | +13.3% | |
| MNST | MONSTER BEVERAGE CORP NEW | $297,370,000 | +9.5% | 4,679,308 | 0.0% | 34.29% | -9.1% | |
| IWM | ISHARES TRrussell 2000 etf | $69,581,000 | +9.5% | 420,000 | 0.0% | 8.02% | -9.1% | |
| AXON | AXON ENTERPRISE INC | $55,697,000 | +29.1% | 760,062 | 0.0% | 6.42% | +7.2% | |
| LCTX | LINEAGE CELL THERAPEUTICS IN | $30,265,000 | -9.2% | 34,005,379 | 0.0% | 3.49% | -24.6% | |
| OCX | Buy | ONCOCYTE CORPORATION | $27,618,000 | +18.5% | 12,274,738 | +10.6% | 3.18% | -1.5% |
| AGE | AGEX THERAPEUTICS INC | $5,455,000 | -7.1% | 2,997,156 | 0.0% | 0.63% | -22.8% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STAAR SURGICAL CO | 42 | Q3 2023 | 59.1% |
| MONSTER BEVERAGE CORP NEW | 34 | Q3 2023 | 49.7% |
| ISHARES TR | 33 | Q3 2023 | 14.8% |
| ONCOCYTE CORPORATION | 31 | Q2 2023 | 4.6% |
| BIOTIME INC | 25 | Q2 2019 | 17.8% |
| AXON ENTERPRISE INC | 24 | Q3 2023 | 13.4% |
| AGEX THERAPEUTICS INC | 20 | Q3 2023 | 1.5% |
| LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 5.1% |
| ASTERIAS BIOTHERAPEUTICS INC | 16 | Q4 2018 | 2.9% |
| CYNOSURE INC | 15 | Q4 2016 | 10.4% |
View BROADWOOD CAPITAL INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 4 | 2024-01-10 |
| 4 | 2024-01-05 |
| 4 | 2023-11-30 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-11-14 |
| 4 | 2023-11-09 |
| 4 | 2023-11-06 |
View BROADWOOD CAPITAL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.